Cargando…
Clinical utility and patient consideration in the use of lenalidomide for multiple myeloma in Chinese patients
Multiple myeloma (MM) is an incurable hematologic malignancy caused by the autonomous growth of malignant plasma cells. In the last decade, the introduction of novel targeted agents such as thalidomide, bortezomib, and lenalidomide has dramatically improved the clinical outcome of MM patients in bot...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459627/ https://www.ncbi.nlm.nih.gov/pubmed/26082645 http://dx.doi.org/10.2147/OTT.S65762 |